• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Analysis of simultaneous allotransplantation of small intestine and liver

Research Project

Project/Area Number 03670586
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionOsaka University

Principal Investigator

FUKUZAWA Masahiro  Pediatric Surgery, Osaka Univ Med. Sch. Assistant Professor, 医学部, 助手 (60165272)

Co-Investigator(Kenkyū-buntansha) FUKUI Yuichi  Pediatric Surgery, Osaka Univ. Med. Sch. Assistant Professor, 医学部, 助手 (30218896)
Project Period (FY) 1991 – 1992
KeywordsSmall intestine / allotransplantation / FK506 / T cell function
Research Abstract

The first series of experiments examined the effect of intra-muscular(im) administration of FK506 on small intesitine allo-graft survival. DA and LEW rats were used as small intestine donors and recipients. FK506 (0.3mg/kg, 1.0mg/kg or 2mg/kg) was given im for 14 days after transplantation. The results clearly demonstrated that the rejection of small intestine allograft was suppressed by FK506 at the dosage of 2.0mg/kg per day, whereas, as a complication of this drugs, all rats died of pneumonia. In order to diminish the requirements for high doses of FK506 in recipients of small intestine allograft, we tried to investigate the effect simultaneous allotransplantation of small intestine and liver. However, recipients died of infection. We changed the protocol to analyze the effect of donor-specific transfusion (DST) and FK506 on small intestine allotransplantation. Recipients (LEW) received 1.5 ml of freshly drawn DA blood iv on day -8 with respect to grafting ( day 0 ). FK506 was administered at a dose of 1.0mg/kg per day from day -8 to day -4, and at 0.3mg/kg per day from day 0 to day +14. The results clearly demonstrated that FK506 combined with DST is effective to prevent acute rejection. Longterm allograft survival could be obtained by conditioning with combined DST and low-dose FK506. To test for in vivo effects of DST+FK506 on T cell function , CTL and IL-2 production were tested in rats treated with DST+FK506. The results suggested that DST+FK506 resulted in selective inhibition of anti-DA T-cell responses without suppressing T-cell responses to third party alloantigens.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] M.FUKUZAWA: "Effect of donor-specific transfusion and FK506 on small intestine allotransplantation" Transplantation Proceedings. 23. 3252-3254 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.F.Santiago: "Effect of donor pretreatment with FK506 upon small intestine allotransplantation in rats" Transplantation Proceedings. 23. 3243-3245 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 福澤 正洋: "ラット小腸移植におけるdonor specific transfusion(DST)とFK506併用療法による免疫不応答性" 今日の移植. 5. 571-575 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 福澤 正洋: "小腸移植研究の現状と拒絶反応への対応" 医学のあゆみ. 163. 819-822 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Fukuzawa, S. Santiago, S. Nakata, R. Shirakura, and A. Okada: "Effect of Donor-Specific Transfusion and FK506 on Small Intestine Allotransplantation" Transplantation Proceedings. 23. 3252-3254 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.F. Santiago, M, Fukuzawa, T. Azuma, and A. Okada: "Effect of Donor Pretreatment With FK506 Upon Small Intestine Allotransplantation in Rats" Transplantation Proceedings. 23. 3243-3245 (1991)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi